NFG
REGN icon

Nations Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Nations Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,082
Closed -$1.14M – 704
2024
Q3 		$1.14M Buy
1,082
+37
+4% +$41.2K 0.08% 254
2024
Q2 		$1.1M Sell
1,045
-21
-2% -$20.4K 0.09% 244
2024
Q1 		$1.03M Buy
1,066
+135
+15% +$128K 0.09% 257
2023
Q4 		$818K Buy
931
+6
+0.6% +$4.94K 0.08% 275
2023
Q3 		$761K Buy
925
+13
+1% +$10.2K 0.08% 274
2023
Q2 		$655K Sell
912
-2
-0.2% -$1.54K 0.06% 319
2023
Q1 		$751K Buy
914
+43
+5% +$32.4K 0.08% 274
2022
Q4 		$628K Sell
871
-21
-2% -$15.5K 0.07% 306
2022
Q3 		$614K Sell
892
-64
-7% -$40.3K 0.09% 246
2022
Q2 		$565K Buy
956
+1
+0.1% +$650 0.08% 282
2022
Q1 		$667K Buy
955
+70
+8% +$44.3K 0.08% 269
2021
Q4 		$559K Buy
885
+25
+3% +$15.4K 0.07% 276
2021
Q3 		$521K Sell
860
-26
-3% -$16.1K 0.08% 259
2021
Q2 		$495K Buy
886
+32
+4% +$16.2K 0.08% 258
2021
Q1 		$404K Sell
854
-172
-17% -$83.7K 0.09% 248
2020
Q4 		$496K Sell
1,026
-12
-1% -$6.48K 0.13% 198
2020
Q3 		$581K Buy
1,038
+194
+23% +$118K 0.18% 151
2020
Q2 		$526K Buy
844
+130
+18% +$73.8K 0.19% 157
2020
Q1 		$349K Buy
+714
New +$295K 0.15% 171

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nations Financial Group's REGN Position: Q4 2024 in Review

Nations Financial Group sold out of Regeneron Pharmaceuticals (REGN) in Q4 2024, closing a stake of 1,082 shares — an estimated $1.14M sold.

Nations Financial Group first reported a position in REGN in Q1 2020 and held it in 19 quarters. The position peaked at $1.14M in Q3 2024. 1,321 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

  • Nations Financial Group reported no remaining Regeneron Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Nations Financial Group sold 1,082 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $1.14M.
  • Nations Financial Group first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 19 quarters.
  • Nations Financial Group's Regeneron Pharmaceuticals position peaked at $1.14M in Q3 2024.
  • 1,321 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on Nations Financial Group's 13F filing for Q4 2024, filed 30 Jan 2025.